Title
Respiratory control in residents at high altitude: Physiology and pathophysiology
Date Issued
01 June 2006
Access level
metadata only access
Resource Type
journal article
Author(s)
Abstract
Highland population (HA) from the Andes, living above 3000 m, have a blunted ventilatory response to increasing hypoxia, breathe less compared to acclimatized newcomers, but more, compared to sea-level natives at sea level. Subjects with chronic mountain sickness (CMS) breathe like sea-level natives and have excessive erythrocytosis (EE). The respiratory stimulation that arises through the peripheral chemoreflex is modestly less in the CMS group when compared with the HA group at the same PETO2. With regard to CO2 sensitivity, CMS subjects seem to have reset their central CO2 chemoreceptors to operate around the sea-level resting PETCO2. Acetazolamide, an acidifying drug that increases the chemosensitivity of regions in the brain stem that contain CO2/H+-sensitive neurons, partially reverses this phenomenon, thus, providing CMS subjects with the possibility to have high CO2 changes, despite small changes in ventilation. However, the same type of adjustments of the breathing pattern established for Andeans has not been found necessarily in Asian humans and/or domestic animals nor in the various high altitude species studied. The differing time frames of exposure to hypoxia among the populations, as well as the reversibility of the different components of the respiratory process at sea level, provide key concepts concerning the importance of time at high altitude in the evolution of an appropriate breathing pattern. © Mary Ann Liebert, Inc.
Start page
125
End page
137
Volume
7
Issue
2
Language
English
OCDE Knowledge area
Fisiología
Medicina integral, Medicina complementaria
Subjects
Scopus EID
2-s2.0-33745879431
PubMed ID
Source
High Altitude Medicine and Biology
ISSN of the container
15270297
Sources of information:
Directorio de Producción Científica
Scopus